Company intelligence / Profile preview

HBM Healthcare Investments

Zug, Zug, Switzerlandhbmhealthcare.com ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

HBM Healthcare Investments is a Swiss-based investment firm with approximately $2.0 billion in assets under management as of April 2025. It holds a globally diversified portfolio of private and public healthcare companies across biotech, medtech, diagnostics and digital health sectors. The majority of its investments are made after proof-of-concept or major clinical/regulatory milestones have been achieved by the target companies. Its strategy has resulted in over 70 trade sales or IPOs over the last decade.

Modalities: Small moleculeMonoclonal antibodyBispecific monoclonal antibodyPeptidesOligonucleotides
Industry: Investors

Partnerships

As an investment firm it partners with venture funds and co-investors rather than forming traditional pharma partnerships.

Beyond the preview

Go deeper on HBM Healthcare Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HBM Healthcare Investments.

Explore the full profile